BioHive Live Recap

Posted on

BioHive Live, BioHive’s inaugural industry-wide event with over 350 registrants took center stage at the Hale Center Theatre in Sandy, Utah on Wednesday. The event featured a series of thought-provoking speakers who engaged, inspired and challenged the audience. Jared Bauer, CEO of Seek Labs and BioHive board chair, welcomed attendees along with Aimee Edwards, BioHive […]

Read More

EDWARDS LAUNCHES THE SAPIEN 3 ULTRA RESILIA VALVE IN EUROPE WITH TECHNOLOGY TO ENHANCE DURABILITY

Posted on

NYON, Switzerland–(BUSINESS WIRE)– Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.* Edwards’ SAPIEN 3 Ultra RESILIA valve recently received CE Mark† for use in patients with heart valve disease […]

Read More

Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business

Posted on

SALT LAKE CITY, May 07, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the reorganization of its European operations to better align company resources to its domestic opportunities while continuing to serve key biopharma partners and patients outside the United States. As part of […]

Read More

Ultradent Announces Acquisition of Ease-In-Shields™ Laser Protection

Posted on

Ultradent proudly announces the acquisition of Ease-In-Shields™ from ViewMax Solutions, LLC. Ease-In-Shields provides unique eye protection for laser and curing light users, with their double patented shape, allowing the shields to fit into most loupe and eyewear shapes for maximum safety. Of the Ease-in-Shield acquisition, Scot Andersen, Ultradent’s Vice-President of Business Development, said, “After years […]

Read More

Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatments

Posted on

SALT LAKE CITY, UT (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced today the successful completion of a therapeutic trial using innovative CRISPR-based technologies to target the African Swine Fever Virus (ASFV) in pigs. The trial, which aimed to replicate and expand […]

Read More